Cannabis stocks jumped Friday as the White House moved to significantly ease federal restrictions on marijuana. Brandon Gomez has the latest on the timing of a potential Executive Order and why the industry says it's “more optimistic” this time around.
With 2026 showing to be a big year for reform, how will this impact marijuana stocks? Looking back over the years, it is clear that marijuana stocks have seen their best trading when positive news on reform is released. The speculation of what could happen drives the market action up often. If investors feel the reform is important enough, you'll then see some increased buying action.
The big question for marijuana stock investors is how the market will react to the newly passed bill to reverse the 2018 Farm Bill. A new bill was recently passed with language that essentially overturned the Hemp laws in the USA. Many legal operators produced hemp and CBD products to ensure compliance under the bill as a way to energetically take part in the industry. Now, legal operators in legal states cultivating cannabis vs hemp have an entirely different legal road map to follow. Yet this is what many are calling a step backwards, and rightfully so.
| Specialty Retail Industry | Consumer Discretionary Sector | Miguel Martin CEO | NASDAQ (CM) Exchange | 05156X884 CUSIP |
| CA Country | 1,073 Employees | - Last Dividend | 20 Feb 2024 Last Split | 11 Jul 2014 IPO Date |
Aurora Cannabis Inc. is a leader in the global cannabis industry, engaging in the production, distribution, and sale of cannabis and its derivatives across Canada and international markets. The company operates through three core segments: Canadian Cannabis, European Cannabis, and Plant Propagation. Its strategies include not only addressing the medical and consumer cannabis markets in Canada but also distributing wholesale medical cannabis throughout the European Union, various international regions such as Australia, the Caribbean, South America, and Israel, and providing supply for propagated vegetables and ornamental plants in North America. Furthermore, Aurora Cannabis extends its presence into the distribution and sale of hemp-derived CBD products. Based in Edmonton, Canada, the company has carved out a competitive position in the global landscape by focusing on diverse product offerings and comprehensive patient counseling and outreach services.
Aurora Cannabis produces a range of consumables including dried cannabis, cannabis oils, and capsules. These products are designed for multiple modes of consumption such as smoking, vaporizing, or ingestion in oil, capsule, or edible form. Each method offers a distinctive experience tailored to consumer and medical patient preferences.
The company's portfolio includes edible cannabis products, extracts, and soft gels. These products provide alternatives for those preferring not to inhale their cannabis, offering a variety of potencies and formulas to suit a diverse client base with specific needs.
Aurora's recreational cannabis products span categories such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products. These offerings fall under brands like Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, enabling Aurora to cater to a broad range of consumer tastes and preferences.
With a focus on patient needs, Aurora offers medical cannabis products under brands such as MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. These products are developed to support patients with specific therapeutic needs, ensuring high quality and efficacy.
Aurora distributes and sells a variety of hemp-derived CBD products, including brands like Reliva and KG7. These products cater to the growing demand for non-psychoactive cannabinoid products, offering benefits without the high associated with THC.
Beyond physical products, Aurora Cannabis extends its services to include patient counseling and outreach. This service demonstrates Aurora's commitment to the well-being of its customers, providing valuable information, support, and guidance on the use of cannabis for medical purposes.